Protalix Biotherapeutics, Inc. to Present at the Oppenheimer 14th Annual Israeli Conference

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CARMIEL, Israel, May 8, 2013 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX), today announced that Dr. David Aviezer, the Company’s President and Chief Executive Officer, will present at the Oppenheimer 14th Annual Israeli Conference on Sunday, May 12, 2013 at 3:35PM IDT. The conference is being held at the David Intercontinental Hotel in Tel Aviv, Israel.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC